Johnny Duerinck

Prof. Johnny Duerinck

orcid

Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
29 March 2021 in Nature Neuroscience
Verified
Journal Article
Closed access
PDF file
AAAna Rita Pombo Antunes
Ana Rita Pombo Antunes
ISIsabelle Scheyltjens
Isabelle Scheyltjens
FLFrancesca Lodi
Francesca Lodi
JMJulie Messiaen
Julie Messiaen
AAAsier Antoranz
Asier Antoranz
KMKiavash Movahedi
Kiavash Movahedi

25 September 2010 in Journal of Neuro-Oncology
Verified
Journal Article
Closed access
PDF file
BNBart Neyns
Bart Neyns
JSJ. Sadones
J. Sadones
CCC. Chaskis
C. Chaskis
MDM. Dujardin
M. Dujardin
HEH. Everaert
H. Everaert
JGJ. De Greve
J. De Greve

24 May 2022 in Neurosurgery
Verified
Journal Article
Closed access
JDJohnny Duerinck
Johnny Duerinck
JVJorn Van Der Veken
Jorn Van Der Veken
SSSophie Schuind
Sophie Schuind
FCFrank Van Calenbergh
Frank Van Calenbergh
JLJohannes van Loon
Johannes van Loon
MBMichaël Bruneau
Michaël Bruneau
BACKGROUND: The mainstay of treatment for symptomatic or large chronic subdural hematoma (CSDH) is surgery, but controversy still exists regarding the best surgical technique. Three different techniques are commonly used: burr hole craniostomy (BHC), minicraniotomy (MC), and twist drill craniostomy (TDC). OBJECTIVE: To determine which surgical technique for drainage of CSDH offers best results. METHODS: We set up a multicenter prospective randomized trial (Comparison of Chronic Subdural Hematoma Treatment [COMPACT] trial) comparing BHC, MC, and TDC for the surgical treatment of CSDH. The primary end point was reoperation rate, and secondary end points included complication rates and clinical outcome. Patients were considered to have good outcome when they did not undergo reoperation, suffered no surgical or medical complication, and had no related mortality. Clinical outcome was also evaluated by evolution of the Markwalder score and the modified Rankin score. RESULTS: Two-hundred forty-five patients were included in the final analysis: 79 BHC, 84 MC, and 82 TDC. Mean duration of surgery was shorter for TDC than for BHC and MC (P < .001). Reoperation rate was 7.6% for BHC, 13.1% for MC, and 19.5% for TDC (P = .07). This trend toward better results for BHC was not statistically significant in logistic regression analysis. The proportion of patients with good outcome was 78.5% for BHC group, 76.2% for MC, and 69.5% for TDC (P = .4). Evolution of the Markwalder score and modified Rankin score were not significantly different between treatment groups. CONCLUSION: All 3 techniques are effective at treating patients with CSDH with eventual 6-month outcome being similar. Although not reaching statistical significance in our study, BHC offers the lowest recurrence rate combined with manageable complication rate.

29 June 2012 in International Journal of Oncology
Verified
Journal Article
Closed access
SLShasha Lv
Shasha Lv
ETErik Teugels
Erik Teugels
JSJan Sadones
Jan Sadones
SBSylvia DE Brakeleer
Sylvia DE Brakeleer
JDJohnny Duerinck
Johnny Duerinck
BNBart Neyns
Bart Neyns
Spandidos Publications is a scientific publisher with a long-standing international reputation for excellent standards and high quality science publications

7 October 2017 in Journal of Neuro-Oncology
Verified
Journal Article
Closed access
JDJohnny Duerinck
Johnny Duerinck
SFS. Du Four
S. Du Four
FBF. Bouttens
F. Bouttens
CAC. Andre
C. Andre
VVV. Verschaeve
V. Verschaeve
BNBart Neyns
Bart Neyns

2 March 2016 in Journal of Neuro-Oncology
Verified
Journal Article
Closed access
PDF file
JDJohnny Duerinck
Johnny Duerinck
SFS. Du Four
S. Du Four
FVF. Vandervorst
F. Vandervorst
NDN. D’haene
N. D’haene
MMM. Le Mercier
M. Le Mercier
BNBart Neyns
Bart Neyns